首页|Institute of Cancer Research Reports Findings in Breast Cancer (Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal depe ndencies in invasive lobular breast cancer)
Institute of Cancer Research Reports Findings in Breast Cancer (Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal depe ndencies in invasive lobular breast cancer)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Breast Canc er is the subject of a report. According tonews reporting originating from Lond on, United Kingdom, by NewsRx correspondents, research stated,“Invasive Lobular Carcinoma (ILC) is a morphologically distinct breast cancer subtype that repres ents upto 15% of all breast cancers. Compared to Invasive Breast Carcinoma of No Special Type (IBC-NST),ILCs exhibit poorer long-term outcome an d a unique pattern of metastasis.”
LondonUnited KingdomEuropeBiomarke rsBreast CancerCancerChemotherapyCyborgsDiagnostics and ScreeningDru gs and TherapiesEmerging TechnologiesHealth and MedicineMachine LearningOncologyWomen’s Health
NETL
NSTL
